Cannabis to Schedule 3? Who are the Winners, the Whiners, and the Losers? It has been over a week so how do you feel about...
The Maine regulatory body overseeing the adult-use cannabis market is introducing new regulations to improve consumer accessibility. These modifications, driven by recent record-breaking sales, are primarily...
Major banks like JPMorgan Chase and Wells Fargo, as well as landlords such as BentallGreenOak and Ashkenazy Acquisition Corp., have found themselves indirectly involved with New...
A group opposed to the legalization of marijuana is targeting a financial agreement between Wells Fargo and the state of Maryland. This arrangement enables state officials...
Over the last several months there has been a lot going on in New York’s cannabis world, with the “highlights” being litigation, corporate letters, municipal legislation,...
In recent years, the growing acceptance and legalization of marijuana for recreational and medicinal use have spurred extensive research into its effects on health and well-being....
Survey Says Most People Who Take Psychedelics Don’t Tell Their Doctors Should You Disclose Psychedelic Use To Your Physician? Some cities in Canada have decriminalized...
According to recently released data from Health Canada to MJBizDaily, Canada’s medical cannabis exporters found their most significant markets in Australia and Israel last year. During...
The Average Day of a Stoner Hobbit in the Shire I’d like to preface this article with the caution to “not try this”, even though,...
Last week, the Department of Health and Human Services (HHS) recommended rescheduling cannabis from schedule I to III under the Controlled Substances Act (CSA). My colleagues already...